[Quetiapine and hypersexuality: Two case reports]

Guillaume Meyer; Pauline Jumeau; Aurore Fichter; Charles-Louis Kel; Bruno Michel; Hervé Javelot

doi:10.1016/j.therap.2021.04.007

[Quetiapine and hypersexuality: Two case reports]

Therapie. 2022 May-Jun;77(3):381-384. doi: 10.1016/j.therap.2021.04.007. Epub 2021 Apr 21.

[Article in French]

Authors

Guillaume Meyer¹, Pauline Jumeau², Aurore Fichter³, Charles-Louis Kel², Bruno Michel⁴, Hervé Javelot⁵

Affiliations

¹ Service pharmacie, EPSAN, 67170 Brumath, France; Service pharmacie, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France; Association « PharmacoPsy Alsace », EPSAN, 67170 Brumath, France. Electronic address: guillaume.meyer@ch-epsan.fr.
² Pôle psychiatrie G06, EPSAN, 67170 Brumath, France.
³ Cabinet libéral, 67000 Strasbourg, France.
⁴ Service pharmacie, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France; Association « PharmacoPsy Alsace », EPSAN, 67170 Brumath, France.
⁵ Service pharmacie, EPSAN, 67170 Brumath, France; Association « PharmacoPsy Alsace », EPSAN, 67170 Brumath, France.

PMID: 33985838
DOI: 10.1016/j.therap.2021.04.007

No abstract available

Keywords: Bipolar disorder; Drug-related side effects and adverse reactions; Effets secondaires indésirables des médicaments; Fumarate de quétiapine; Masturbation; Psychological; Quetiapine fumarate; Sexual dysfunctions; Trouble bipolaire; Troubles du désir sexuel.

Publication types

Case Reports
Letter

MeSH terms

Antipsychotic Agents* / adverse effects
Bipolar Disorder* / drug therapy
Dibenzothiazepines / therapeutic use
Humans
Quetiapine Fumarate / therapeutic use

Substances

Antipsychotic Agents
Dibenzothiazepines
Quetiapine Fumarate